Semax Research Overview
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragments 4-7, modified with an additional Pro-Gly-Pro C-terminal sequence. This melanocortin analogue represents a significant advancement in neuropeptide research, originally developed in Russia for investigating neuroprotective pathways and cognitive enhancement mechanisms. Researchers examining neural tissue models frequently source Semax from Stroid UK Shop for its consistent quality standards and laboratory-grade purity specifications.
The peptide functions through modulation of brain-derived neurotrophic factor (BDNF) expression and enhancement of neurotrophic factor production in experimental neural tissue cultures. Research applications focus on ischaemic stroke models, where Semax demonstrates protective effects against oxidative damage in cell-based assays. Scientists investigating neuroprotective compounds often examine this peptide alongside other research materials available in the other drugs category for comprehensive comparative studies.
Laboratory Applications
Semax research primarily centres on its neuroprotective properties in cellular stress models. Laboratory studies examine its influence on synaptic plasticity, memory formation pathways, and neural regeneration processes in various experimental systems. The compound’s stability and reproducible effects make it valuable for researchers studying melanocortin receptor interactions and downstream signalling cascades. Many laboratories combine Semax investigations with selective androgen receptor modulators to study complex neurohormonal interactions in tissue culture models.
Current research directions include examination of Semax effects on neuroinflammation markers, acetylcholine pathway modulation, and dopaminergic system function in experimental preparations. The peptide’s mechanism involves activation of specific receptor subtypes that influence gene expression patterns associated with neural protection and cognitive function. Researchers frequently investigate Semax alongside other neuropeptides from the peptides collection for synergistic effect studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 80714-61-0 |
| Molecular Formula | C₃₇H₅₁N₉O₁₀S |
| Molecular Weight | 813.93 g/mol |
| Purity | ≥98% (HPLC) |
| Storage | 2-8°C, protected from light |
| Solubility | Water soluble |
| Stability | 24 months unopened |
Research Compliance
This Semax 5mg formulation from Dragon Pharma is manufactured exclusively for in-vitro research applications and laboratory investigation purposes. The product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional oversight, proper storage conditions, and adherence to local regulations governing research chemical handling and disposal procedures.
